Hypofractionated Radiochemotherapy

PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 26, 2025

Primary Completion Date

July 1, 2026

Study Completion Date

July 1, 2028

Conditions
Uterine Cervix Cancer
Interventions
DRUG

Cisplatin

A total of two IV infusions of cisplatin will be administered on Day 1 and again on Day 8 +/- 1 day. Cisplatin starting dose is 40 mg/m2. Dose reduction is allowed (30 mg/m2) as needed for management of toxicities.

RADIATION

intensity modulated radiation therapy (IMRT)

given once daily Monday-Thursday, four fractions per week for 2 weeks. The radiation dose is 4.56 Gy x 8 fractions.

RADIATION

high-dose-rate (HDR) brachytherapy

administered 2x weekly (allow at least 72-hours window between sessions); weekdays only for 2 weeks. The radiation dose is 7 Gy x 4 fractions.

Trial Locations (1)

40506

RECRUITING

Markey Cancer Center, Lexington

All Listed Sponsors
lead

Denise Fabian

OTHER

NCT06331468 - Hypofractionated Radiochemotherapy | Biotech Hunter | Biotech Hunter